QNTM vs. QTUM
QNTM (Quantum BioPharma Ltd) is a stock, while QTUM (Defiance Quantum ETF) is Technology Equities fund tracking the BlueStar Machine Learning and Quantum Computing Index. Over the past 5 years, QNTM returned -50.26%/yr vs 29.55%/yr for QTUM. At a 0.21 correlation, their price movements are largely independent.
Performance
QNTM vs. QTUM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNTM achieves a -49.86% return, which is significantly lower than QTUM's 54.06% return.
QNTM
- 1D
- -3.68%
- 1M
- -60.39%
- YTD
- -49.86%
- 6M
- -65.76%
- 1Y
- -89.54%
- 3Y*
- -65.06%
- 5Y*
- -50.26%
- 10Y*
- —
QTUM
- 1D
- 0.38%
- 1M
- 9.88%
- YTD
- 54.06%
- 6M
- 50.57%
- 1Y
- 94.08%
- 3Y*
- 52.80%
- 5Y*
- 29.55%
- 10Y*
- —
QNTM vs. QTUM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
QNTM Quantum BioPharma Ltd | -49.86% | 98.37% | -93.84% | 16.67% | -22.71% | -34.62% | -71.27% | -87.38% | -17.05% |
QTUM Defiance Quantum ETF | 54.06% | 36.65% | 50.54% | 39.86% | -28.80% | 35.18% | 42.05% | 47.99% | -19.44% |
Correlation
The correlation between QNTM and QTUM is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 5, 2018 | 0.21 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNTM vs. QTUM — Risk / Return Rank
QNTM
QTUM
QNTM vs. QTUM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and Defiance Quantum ETF (QTUM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QNTM | QTUM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.85 | ||
| Sortino ratioReturn per unit of downside risk | -4.93 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.51 | -0.64 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 6.20 | -7.17 |
| Martin ratioReturn relative to average drawdown | -1.32 | 22.37 | -23.68 |
Loading charts...
Drawdowns
QNTM vs. QTUM - Drawdown Comparison
The maximum QNTM drawdown since its inception was -99.98%, which is greater than QTUM's maximum drawdown of -38.45%. Use the drawdown chart below to compare losses from any high point for QNTM and QTUM.
Loading charts...
Drawdown Indicators
| QNTM | QTUM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -38.45% | -61.53% |
Max Drawdown (1Y)Largest decline over 1 year | -92.81% | -15.26% | -77.55% |
Max Drawdown (3Y)Largest decline over 3 years | -97.98% | -25.39% | -72.59% |
Max Drawdown (5Y)Largest decline over 5 years | -98.42% | -38.45% | -59.97% |
Current DrawdownCurrent decline from peak | -99.96% | -0.09% | -99.87% |
Average DrawdownAverage peak-to-trough decline | -92.23% | -8.23% | -84.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 72.57% | 4.22% | +68.35% |
Volatility
QNTM vs. QTUM - Volatility Comparison
Quantum BioPharma Ltd (QNTM) has a higher volatility of 44.82% compared to Defiance Quantum ETF (QTUM) at 14.55%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than QTUM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNTM | QTUM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 44.82% | 14.55% | +30.27% |
Volatility (6M)Calculated over the trailing 6-month period | 110.58% | 23.47% | +87.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 154.88% | 28.95% | +125.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 134.18% | 27.13% | +107.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 140.37% | 27.46% | +112.91% |
Dividends
QNTM vs. QTUM - Dividend Comparison
QNTM has not paid dividends to shareholders, while QTUM's dividend yield for the trailing twelve months is around 0.70%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
QNTM Quantum BioPharma Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QTUM Defiance Quantum ETF | 0.70% | 1.01% | 0.61% | 0.81% | 1.46% | 0.48% | 0.42% | 0.61% | 0.21% |
Frequently Asked Questions
QNTM and QTUM have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNTM has higher volatility (44.82%) compared to QTUM (14.55%). In terms of maximum drawdown, QNTM dropped -99.98% vs QTUM's -38.45%.
QTUM currently has the higher Sharpe Ratio (3.27 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNTM and QTUM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer